Abstract
We designed and synthesized a 7-azaindole derivative(TH1082), which was characterized by 1H NMR and 13C-NMR. We investigated its antitumor effects on human melanoma A375 cells, human liver cancer SMMC cells and human breast cancer MCF-7 cells in vitro via 3-(4,5-dimethyldiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay and also explored the mechanism of antiproliferation of them. The results show that TH1082 significantly inhibited the proliferation of these cells to different extent. The IC50 values for A375 cells, SMMC cells and MCF-7 cells were 25.38, 48.70 and 76.94 μg/mL at 24 h, respectively. To observe cell morphological changes, acridine orange/ethidium bromide(AO/EB) staining and Hoechest33342/PI staining were carried out. These results indicate that TH1082 could induced the apoptosis of A375 cells. The apoptotic rates were (9.5±2.09)%, (18.9±2.25)% and (39.5±2.02)%(5, 10 and 20 μg/mL) for A375, SMMC and MCF-7 cell lines, respectively. Further, we determined the activities of caspase-3 and caspase-9 in A375 cells treated with TH1082 at different concentrations(0, 5, 10 and 20 μg/mL) or Z-VAD-FMK(20 μmol/L), a pan-caspase inhibitor for 24 h. The results show that TH1082 activated caspase-3 and caspase-9, and the activation could be blocked by Z-VAD-FMK. Taken together, these findings indicate that TH1082 could inhibit the proliferation of A375 cells via activating caspase-3 and caspase-9.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
References
Cacchi S., Fabrizi G., Chem. Rev., 2005, 105, 2873
Humphrey G. R., Kuethe J. T., Chem. Rev., 2006, 106, 2875
Kochanowska-Karamyan A. J., Hamann M. T., Chem. Rev., 2010, 110, 4489
Jacob A. P., Nicole N. M., Hadi D. A., Andrey P., Kim R. D., Mohan N., Manickam K., Sumathy M., Judith A. W., J. Inorg. Biochem., 2013, 127, 175
Florence P., Sylvain R., Benoît J., Jean-Yves M., Tetrahedron, 2007, 63, 1031
Song J. J., Reeves J. T., Gallou F., Tan Z. T., Yee N. K., Senanayake C. H., Chem. Soc. Rev., 2007, 36, 1120
Zhao S. B., Wang S., Chem. Soc. Rev., 2010, 39, 3142
Lebouvier N., Pagniez F., Duflos M., Pape P. L., Young M. N., Baut G. L., Borgne M. L., Bioorg. Med. Chem. Lett., 2007, 17(13), 3686
Guillard J., Decrop M., Gallay N., Espanel C., Boissier E., Herault O., Viaud-Massuard M., Bioorg. Med. Chem. Lett., 2007, 17(7), 1934
Trejo A., Arzeno H., Browner M., Chanda S., Cheng S., Comer D. D., Dalrymple S. A., Dunten P., Lafargue J., Lovejoy B., Freire-Moar J., Lim J., Mcintosh J., Miller J., Papp E., Reuter D., Roberts R., Sanpablo F., Saunders J., Song K., Villasenor A., Warren S. D., Welch M., Weller P., Whiteley P. E., Zeng L., Goldstein D. M., J. Med. Chem., 2003, 46(22), 4702
Morón M., Burgos C., Alvarez-Builla J., Salgado A., Mosquera M. E. G., Vaquero J. J., Chem. Commun., 2012, 48, 9171
José R., Venancio R., Concepción de H., Arturo E., José P., Christoph J., Dalton Trans., 2010, 39, 3290
Wang T., Wallace O. B., Zhang Z. X., Meanwell N. A., Bender J. A., Antiviral Azaindole Derivatives., US6632819, 2003
Walker S. R., Carter E. J., Huff B. C., Morris J., Chem. Rev., 2009, 109, 3080
Hong S., Lee S., Kim B., Lee H., Hong S., Hong S., Bioorg. Med. Chem. Lett., 2010, 20, 7212
Anthony J., J. Med. Chem., 1972, 15(2), 149
Hugon B., Anizon F., Bailly C., Golsteyn R. M., Pierré A., Léonce S., Hickman J., Pfeiffer B., Prudhomme M., Bioorg. Med. Chem., 2007, 15(17), 5965
Dirk B. M., Laird A. D., Xin X. H., Louie S. G., Christensen J. G., Li G., Schreck R., Abrams T. J., Ngai T. J., Lee L. B., Murray L. J., Carver J., Chan E., Moss K. G., Haznedar J. O., Sukbuntherng J., Blake R. A., Sun L., Tang C., Miller T., Shirazian S., Mcmahon G., Cherrington J. M., Clin. Cancer. Res., 2003, 9, 327
Motzer R. J., Michaelson M. D., Redman B. G., Hudes G. R., Wilding G., Figlin R. A., Ginsberg M. S., Kim S. T., Baum C. M., De-Primo S. E., Li J. Z., Bello C. L., Theuer C. P., George D. J., Rini B. I., J. Clin. Oncol., 2006, 24, 16
O’Farrell A., Abrams T. J., Yuen H. A., Ngai T. J., Louie S. G., Yee K. W. H., Wong L. M., Hong W., Lee L. B., Town A., Smolich B. D., Manning W. C., Murray L. J., Heinrich M. C., Cherrington J. M., Blood, 2003, 101, 3597
Sun L., Liang C., Shirazian S., Zhou Y., Miller T., Cui J., Fukuda J. Y., Chu J. Y., Nematalla A., Wang X. Y., Chen H., Sistla A., Luu T. C., Tang F., Wei J., Tang C., J. Med. Chem., 2003, 46, 1116
Wang H. Y., Ke B. L., Su G. F., Xu X., Chem. Res. Chinese Universities, 2012, 28(6), 1041
Chen C. Y., Chen Y. K., Wang J. J., Hsu C. C., Tsai F. Y., Sung P. J., Lin H. C., Chang L. S., Hu W. P., Cell Biol. Toxicol., 2013, 29, 85
Chen T., Wong Y. S., Cell. Mol. Life Sci., 2008, 65, 2763
Qu X. J., Cui S. X., Tian Z. G., Li X., Chen M. H., Xu W. F., Inagaki Y., Deng Y. B., Makuuchi M., Nakata M., Tang W., Anticancer Res., 2007, 27, 2427
Huang X. J., Li Q., Li H. G., Guo L. J., Cell Mol. Neurobiol., 2009, 29, 1211
Xu H. L., Yu X. F., Qu S. C., Zhang R., Qu X. R., Chen Y. P., Ma X. Y., Sui D. Y., Eur. J. Pharmacol., 2010, 645(1–3), 14
Qu X. R., Qu S. C., Yu X. F., Xu H. L., Chen Y. P., Ma X. Y., Sui D. Y., Oncol. Rep., 2011, 26(6), 1441
Abrams T. J., Lee L. B., Murray L. J., Pryer N. K., Cherrington J. M., Mol. Cancer Ther., 2003, 2, 471
Murray L. J., Abrams T. J., Long K. R., Ngai T. J., Olson L. M., Hong W., Keast P. K., Brassard J. A., O’Farrell A. M., Pryer N. K., Cherrington J. M., Clin. Exp. Metastas., 2003, 20, 757
Abrams T. J., Murray L. J., Pesenti E., Holway V. W., Colombo T., Lee L. B., Cherrington J. M., Pryer N. K., Mol. Cancer Ther., 2003, 2, 1011
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhang, P., Sui, D., Xu, H. et al. Synthesis and antitumor activity of a new 7-azaindole derivative. Chem. Res. Chin. Univ. 30, 420–424 (2014). https://doi.org/10.1007/s40242-014-3468-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-014-3468-5